CRVO CIK: 1053691

CervoMed Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
37.8
FY22:
4.16
FY23:
9.96
FY24:
43.1
FY25:
22.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.02
FY22:
0
FY23:
0.01
FY24:
0
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
37.8
FY22:
4.16
FY23:
9.97
FY24:
43.1
FY25:
22.9

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
2.93
FY22:
–
FY23:
2.60
FY24:
3.88
FY25:
4.66
(negative)
millions USD
FY21:
0
FY22:
–
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
34.9
FY22:
−33.3
FY23:
7.38
FY24:
39.2
FY25:
18.2
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
37.8
FY22:
–
FY23:
9.97
FY24:
43.1
FY25:
22.9

All amounts in millions USD Data sources:SEC EDGARTwelve Data